Automated intelligent software lets compliance officers uncover the misuse of inside information
Compass

Automated intelligent software lets compliance officers uncover the misuse of inside information

Harnesses the insights of behavioural research to dramatically improve investment performance
Edge

Harnesses the insights of behavioural research to dramatically improve investment performance

Welcome to Investment Intelligence

Looking for new ways to improve investment performance or quickly spot insider trading?

We can help you by providing innovative analytical software for the financial industry that uses the power of applied behavioural science. Investment Intelligence serves banks, asset management firms, hedge funds and fund-of-funds worldwide.

Latest news

Pfizer walks away from $118 billion AstraZeneca takeover fight

5/26/2014 4:55:17 PM

LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the...

See you later? Slim Pfizer deal hopes prop up AstraZeneca

5/21/2014 7:23:11 PM

LONDON (Reuters) - Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British...

AstraZeneca rejects Pfizer's take-it-or-leave-it offer

5/19/2014 11:37:37 PM

LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, puncturing the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals...

Pfizer raises bid for AstraZeneca to $117 billion

5/18/2014 11:57:33 PM

LONDON (Reuters) - U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if...

Request a demo